23.10.2015
- Hedge fund manager and activist shareholder Bill Ackman has bought 2 million new shares in Valeant at an estimated total cost of $230 million. The buy is said to have increased his...
30.09.2015
- Shares of US-listed Canadian drugmaker Valeant came under additional severe pressure early this week when Democratic party members on the House of Representative committee on...
04.09.2015
- Canadian drugmaker Valeant has said it will work with AstraZeneca on a potential treatment for psoriasis, brodalumab, taking up the gauntlet from Amgen, which recently curtailed...
24.08.2015
- US specialty drugs company Valeant Pharmaceuticals has agreed to pay $1 billion in cash, on a debt-free basis, for female sexual heath firm Sprout Pharmaceuticals. Under the terms...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
17.03.2015
- Valeant Pharmaceuticals increased its takeover offer for Salix Pharmaceuticals to $10.96 billion in cash, eliminating Endo International, the only other bidder. Salix has agreed to...
16.03.2015
- Dublin, Ireland-based Endo International has made a takeover bid for US drugmaker Salix Pharmaceuticals in an effort to thwart Valeant Pharmaceuticals International's $10 billion...
19.02.2015
- Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...